European Pharmaceutical Review
SEPTEMBER 15, 2023
A modern identity for Janssen The new logo, colors, and font for J&J Innovative Medicine will be rolled out steadily across all company materials, product packaging, and branding assets over time. Branding innovation in the pharmaceutical industry This week, Novartis has also finalised changes to its divisions.
European Pharmaceutical Review
MARCH 15, 2023
It binds to chromatin, which is the braid of DNA and protein packaging within the nucleus; it summons large protein complexes to join it. Menin is a critical part of the cell’s epigenetic mechanism for switching gene activity on and off. The complexes tighten or loosen the coils of DNA, changing gene activity level at that site.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 4, 2022
Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour While highly effective, taxanes also exhibit several of the typical limitations associated with systemic chemotherapies. tumour effects.
Pharmaceutical Technology
MARCH 30, 2023
On March 27, MSD announced that the combined use of Keytruda with chemotherapy significantly improved progression-free survival versus the chemotherapy alone, as a first-line therapy for advanced or recurrent endometrial carcinoma. This announcement is not the only recent development for Keytruda.
epicur
JULY 12, 2023
Chemo Blister Packs For safer, more convenient treatment Epicur® chemotherapy tablets are manufactured in our FDA Registered Outsourcing Facility following cGMP. The unit-dose blister packaging offers key advantages and safer handling for veterinary staff and pet owners. Targeted drug therapy. Immunotherapy.
European Pharmaceutical Review
AUGUST 25, 2022
After surgery, strategic combinations of radiotherapy, chemotherapy like temozolomide, and other forms of treatment, such as immunotherapy or the use of an electric field cap, are employed. For example, radiotherapy and chemotherapy together entails up to six month? Two weeks later, patients began standard radiation and chemotherapy.
pharmaphorum
APRIL 16, 2021
GSK decided to stop enrolling patients on the phase 2 INDUCE-3 trial, discontinuing treatment with feladilimab and has also axed the INDUCE-4 phase 2 trial, testing feladilimab versus placebo in combination with Keytruda and chemotherapy. billion signed with Germany’s Merck KGaA.
Expert insights. Personalized for you.
98 
Let's personalize your content